Suppr超能文献

万古霉素耐药肠球菌在儿科重症监护病房的爆发:成功干预控制和预防的报告。

Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention.

机构信息

Centro de Terapia Intensiva Pediátrico, Departamento de Puericultura e Pediatria, Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brasil.

出版信息

Braz J Med Biol Res. 2012 Feb;45(2):158-62. doi: 10.1590/s0100-879x2012007500005. Epub 2012 Jan 26.

Abstract

The objective of this study is to retrospectively report the results of interventions for controlling a vancomycin-resistant enterococcus (VRE) outbreak in a tertiary-care pediatric intensive care unit (PICU) of a University Hospital. After identification of the outbreak, interventions were made at the following levels: patient care, microbiological surveillance, and medical and nursing staff training. Data were collected from computer-based databases and from the electronic prescription system. Vancomycin use progressively increased after March 2008, peaking in August 2009. Five cases of VRE infection were identified, with 3 deaths. After the interventions, we noted a significant reduction in vancomycin prescription and use (75% reduction), and the last case of VRE infection was identified 4 months later. The survivors remained colonized until hospital discharge. After interventions there was a transient increase in PICU length-of-stay and mortality. Since then, the use of vancomycin has remained relatively constant and strict, no other cases of VRE infection or colonization have been identified and length-of-stay and mortality returned to baseline. In conclusion, we showed that a bundle intervention aiming at a strict control of vancomycin use and full compliance with the Hospital Infection Control Practices Advisory Committee guidelines, along with contact precautions and hand-hygiene promotion, can be effective in reducing vancomycin use and the emergence and spread of vancomycin-resistant bacteria in a tertiary-care PICU.

摘要

本研究旨在回顾一家大学附属医院三级儿科重症监护病房(PICU)中控制万古霉素耐药肠球菌(VRE)爆发的干预措施的结果。在确定爆发后,在以下几个层面采取了干预措施:患者护理、微生物监测以及医护人员培训。数据从基于计算机的数据库和电子处方系统中收集。2008 年 3 月后,万古霉素的使用逐渐增加,2009 年 8 月达到高峰。发现 5 例 VRE 感染,3 例死亡。干预后,我们注意到万古霉素处方和使用显著减少(减少 75%),并且 4 个月后发现最后一例 VRE 感染。幸存者直到出院仍定植。干预后,PICU 住院时间和死亡率短暂增加。此后,万古霉素的使用保持相对稳定和严格,未再发现其他 VRE 感染或定植病例,住院时间和死亡率恢复到基线。总之,我们表明,旨在严格控制万古霉素使用和完全遵守医院感染控制实践咨询委员会指南的一整套干预措施,以及接触预防和手部卫生促进措施,可有效减少三级 PICU 中万古霉素的使用以及万古霉素耐药菌的出现和传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c8/3854257/948f56add0b6/0100-879X-bjmbr-45-02-158-gf01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验